90 related articles for article (PubMed ID: 1771541)
21. [Effect of prostaglandin E1 on arterial ketone body ratio during and after hepatectomy].
Nakayama M; Kanaya N; Fujita S; Kawana S; Namiki A
Masui; 1995 Sep; 44(9):1224-7. PubMed ID: 8523654
[TBL] [Abstract][Full Text] [Related]
22. Oral prostaglandin E1 derivative (OP-1206) in an infant with double outlet right ventricle and pulmonary stenosis. Effect on ductus-dependent pulmonary circulation.
Saji T; Matsuura H; Hoshino K; Yamamoto S; Ishikita T; Matsuo N
Jpn Heart J; 1991 Sep; 32(5):735-40. PubMed ID: 1774835
[TBL] [Abstract][Full Text] [Related]
23. [Intravenous and intra-arterial prostaglandin E1 treatment in patients with stage IIb arterial occlusive disease].
Rudofsky G
Vasa Suppl; 1988; 23():121-5. PubMed ID: 3206330
[No Abstract] [Full Text] [Related]
24. Oral prostaglandin E1 as a therapeutic modality for leg ulcers in Behçet's disease.
Takeuchi A; Hashimoto T
Int J Clin Pharmacol Res; 1987; 7(4):283-9. PubMed ID: 3596871
[TBL] [Abstract][Full Text] [Related]
25. Differential microcirculation dynamics during deliberate hypotension induced by nicardipine, PGE1 and trimethaphan in rat mesentery.
Takakura K; Sugiura Y; Goto Y
Can J Anaesth; 1995 Nov; 42(11):1035-9. PubMed ID: 8590494
[TBL] [Abstract][Full Text] [Related]
26. [Does simultaneous administration of a PGE1 analog prevent indomethacin damage to human gastric mucosa? An endoscopic double-blind study].
Müller P; Dammann HG; Simon B
Z Rheumatol; 1986; 45(2):71-3. PubMed ID: 3524066
[TBL] [Abstract][Full Text] [Related]
27. [Effect of vazaprostan on microcirculation in patients with scleroderma systematic].
Alekperov RT; Mach ES; Guseva NG
Ter Arkh; 2000; 72(10):60-4. PubMed ID: 11220881
[TBL] [Abstract][Full Text] [Related]
28. Cardiopulmonary effects of intravenous prostaglandin E1 during experimental one-lung ventilation.
Bund M; Henzler D; Walz R; Rossaint R; Piepenbrock S
Thorac Cardiovasc Surg; 2006 Aug; 54(5):341-7. PubMed ID: 16902884
[TBL] [Abstract][Full Text] [Related]
29. Amrinone, a selective phosphodiesterase III inhibitor, improves microcirculation and flap survival: a comparative study with prostaglandin E1.
Ichioka S; Nakatsuka T; Sato Y; Shibata M; Kamiya A; Harii K
J Surg Res; 1998 Feb; 75(1):42-8. PubMed ID: 9614855
[TBL] [Abstract][Full Text] [Related]
30. Prostaglandin E1 infusion compared with prostacyclin infusion in patients with refractory heart failure: effects on hemodynamics and neurohumoral variables.
Pacher R; Stanek B; Hülsmann M; Bojic A; Berger R; Frey B; Siegel A; Kos T; Ogris E; Grimm M; Laufer G
J Heart Lung Transplant; 1997 Aug; 16(8):878-81. PubMed ID: 9286780
[TBL] [Abstract][Full Text] [Related]
31. The effects of prostaglandin E1 on hepatic allograft vascular inflow: a prospective randomized double-blind study.
Chavin KC; Uber L; Baliga P; Rajagopalan P; Coder JB
Am Surg; 1996 Mar; 62(3):184-7. PubMed ID: 8607575
[TBL] [Abstract][Full Text] [Related]
32. 6-Keto-prostaglandin E1 is a potent coronary vasodilator and stimulates a vagal reflex in dogs.
Panzenbeck MJ; Hintze TH; Kaley G
J Pharmacol Exp Ther; 1988 Mar; 244(3):814-9. PubMed ID: 3075239
[TBL] [Abstract][Full Text] [Related]
33. [The effects of prostaglandin E1 and epidural anesthesia on peripheral blood flow].
Sakuma K; Fukuda S; Shimoji K
Masui; 1995 Oct; 44(10):1350-5. PubMed ID: 8538002
[TBL] [Abstract][Full Text] [Related]
34. Vasodilator therapy after heart transplantation: effects of inhaled nitric oxide and intravenous prostacyclin, prostaglandin E1, and sodium nitroprusside.
Kieler-Jensen N; Lundin S; Ricksten SE
J Heart Lung Transplant; 1995; 14(3):436-43. PubMed ID: 7654728
[TBL] [Abstract][Full Text] [Related]
35. Circulation parameters during intravenous and intra-arterial administration of increasing doses of prostaglandin E1 in healthy subjects.
Brecht T; Ayaz M
Klin Wochenschr; 1985 Dec; 63(23):1201-4. PubMed ID: 4087829
[TBL] [Abstract][Full Text] [Related]
36. Effects on improvement of blood flow in the chronically compressed cauda equina: comparison between a selective prostaglandin E receptor (EP4) agonist and a prostaglandin E1 derivate.
Sekiguchi M; Konno S; Kikuchi S
Spine (Phila Pa 1976); 2006 Apr; 31(8):869-72. PubMed ID: 16622373
[TBL] [Abstract][Full Text] [Related]
37. Beneficial effects of intravenous administration of lipo-prostaglandin E1 on the ischemic gastric tube in pigs.
Tobari S; Ikeda Y; Takami H
J Surg Res; 2005 Nov; 129(1):79-84. PubMed ID: 16087193
[TBL] [Abstract][Full Text] [Related]
38. Effects of prostaglandin E1alpha cyclodextrin [corrected] treatment on endothelial dysfunction in patients with systemic sclerosis.
Giannattasio C; Pozzi M; Gardinali M; Montemerlo E; Citterio F; Maestroni S; Fantini E; Failla M; Robuschi M; Bianco S; Mancia G
J Hypertens; 2007 Apr; 25(4):793-7. PubMed ID: 17351371
[TBL] [Abstract][Full Text] [Related]
39. Prostaglandin E1 resuscitates hepatic organic anion transport independent of its hemodynamic effect after warm ischemia.
Shinohara H; Tanaka A; Fujimoto T; Kanazawa A; Satoh S; Hatano E; Yamaoka Y
J Surg Res; 1997 Feb; 68(1):56-62. PubMed ID: 9126195
[TBL] [Abstract][Full Text] [Related]
40. [Hypercholesterolemia reduces prostaglandin E1-induced improvement in microcirculation--an animal experiment study].
Hertel RF; Creutzig A
Vasa Suppl; 1992; 35():34-5. PubMed ID: 1481054
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
